how safe are glp 1 drugs GLP-1 Medications Infographic GLP-1 Drugs from the Gray

J., Rosenstock, J., Manghi, F

Rao SSC

Despite this growth, access to GLP-1RAs remains uneven globally

Heterogeneity was assessed using the I 2 statistic and Cochrans Q test

475,480,481 The encouraging results obtained with semaglutide in patients with heart failure and a preserved ejection fraction may provide a new option for this patient population, in which additional therapy, as well as another upstream therapy for patients with a higher BMI who have indications for this condition, is urgently needed

A similar finding was reported in an analysis of adverse drug reactions using the World Health Organization pharmacovigilance database VigiBase (92)